首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Ghrelin as a target for gastrointestinal motility disorders
Authors:Greenwood-Van Meerveld Beverley  Kriegsman Michael  Nelson Richard
Institution:a Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
b Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
c Veterans Affairs Medical Center, Oklahoma City, OK, United States
d Veterans Affairs Medical Center, Morristown, NJ, United States
Abstract:The therapeutic potential of ghrelin and synthetic ghrelin receptor (GRLN-R) agonists for the treatment of gastrointestinal (GI) motility disorders is based on their ability to stimulate coordinated patterns of propulsive GI motility. This review focuses on the latest findings that support the therapeutic potential of GRLN-R agonists for the treatment of GI motility disorders. The review highlights the preclinical and clinical prokinetic effects of ghrelin and a series of novel ghrelin mimetics to exert prokinetic effects on the GI tract. We build upon a series of excellent reviews to critically discuss the evidence that supports the potential of GRLN-R agonists to normalize GI motility in patients with GI hypomotility disorders such as gastroparesis, post-operative ileus (POI), idiopathic chronic constipation and functional bowel disorders.
Keywords:Ghrelin  Motility  Gastrointestinal tract
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号